Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIBOCICLIB: Safety Overview

Metric REZAFUNGIN RIBOCICLIB
Total FAERS Reports 108 27,997
Deaths Reported 12 4,501
Death Rate 11.1% 16.1%
Hospitalizations 20 6,700
Average Patient Age 53.8 yrs 60.2 yrs
% Female Patients 54.3% 99.0%
FDA Approval Date Mar 22, 2023 Mar 13, 2017
Manufacturer Melinta Therapeutics, LLC Novartis Pharmaceuticals Corporation
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription